Purchase Order W81K0022P0265
Award Date
10/1/22
Potential Completion Date
9/30/27
Potential Value
$187K
Federal Agency
Medical Command
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
This is a delivery order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Immucor Inc. for the annual supply of blood testing reagents. The award, which has a ceiling value of $130,059.42, is made under Immucor's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. As a firm fixed-price contract, this delivery order does not utilize any set-aside designations. Immucor is a leading provider of automated...
This is a firm fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The $7,653.03 contract is for the provision of blood bank reagents and supplies under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The contract does not have a set-aside designation. Immucor holds several significant Indefinite Delivery/Blanket Purchase...
This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract is for a base year plus four option years, with a ceiling value of $29,848.00, for the provision of blood bank reagents. The contract is issued under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and does not have a set-aside designation. Immucor is a key supplier of...
This is a delivery order contract awarded to Immucor Inc. by the Department of the Army Medical Command for the provision of blood typing reagents. The contract has a potential value of $120,612.04 and a completion date of September 30, 2019. Immucor Inc. is a manufacturer of in vitro diagnostic products, reagents, and test kits for blood transfusion and transplantation compatibility testing. The contract was not set aside for any specific business category. Immucor has held previous federal...
This federal contract award to Immucor Inc., a for-profit manufacturer, is for the provision of reagents and an echo analyzer to support blood bank operations. The $784,855.51 firm fixed price purchase order was awarded on October 1, 2016 by the Medical Command division of the Department of Defense, with a period of performance through September 30, 2019. No set-aside designation was used. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood...
This contract award to Immucor Inc. is for the delivery of in vitro diagnostic reagents, test kits, and associated equipment on a Firm Fixed Price basis. The contract is funded by the Defense Health Agency and the award has a potential value of $153,884.39. Immucor, a for-profit manufacturer, is providing these specialized medical supplies and services to support blood transfusion and transplantation compatibility testing programs for federal health networks and military treatment facilities....
This is a firm fixed-price delivery order awarded by the Department of Defense's Bureau of Medicine and Surgery to Immucor Inc., a for-profit manufacturer of in vitro diagnostic reagents and test kits. The $26,437.30 contract was issued under Immucor's General Services Administration (GSA) Federal Supply Schedule 65-VII for Invitro Diagnostics, Reagents, and Test. The order is for ITEM CODE 0002225 and did not have a set-aside designation. Through this and other contracts, Immucor has provided a...
This is a $4,970.47 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract provides Immucor's specialized reagents, blood analyzers, testing equipment, and related consumables to support blood typing, compatibility testing, antibody screening, and critical blood banking operations within federal health networks and military treatment centers. Immucor has a...